<< I’m really favorably impressed by the enthusiasm that customers and some speakers expressed against MLS® Laser Therapy and by results obtained from its application. The personal experiences that have been brought to my attention telling of relevant success stories. Since 2012, when MLS ® Laser Therapy has been presented for the first time during the BioRESEARCH Annual Conference, much progress has been made, despite having spent only one year: from simple curiosity, insiders have switched to competent and effective use, showing more and more interest in jobs and deepen protocols>>. With these words Lucio Zaghetto, CEO of ASAlaser, commented the company's participation at 2013 edition of "The Annual Conference", conference of international experts in field of TMD (Cranio Facial Pain and Sleep Disorders) held in Milwaukee. From May 2 to 4, in the course of the congress, which saw the participation of Russians, Poles, Indians and Canadians doctors, MLS® has played a leading role. << The confirmation comes from the inclusion of the training centered on MLS ® Laser Therapy in the conference program, and from the attention that dr. Mike Smith, dr. Dave Shirazy and dr. John Nosti have given to the therapy on their speeches, even telling personal success stories. In particular, in his speech dr. Shirazi explained the benefits of MLS ® Laser to accelerate the treatment of temporomandibular joint disorders, also performing two sections of training with specific focus on MLS ® Laser Therapy as integrated system for the treatment of TMD (Temporomandibular disorders) and TMJ (temporomandibular joints). <<Even dr. Ed Lipskis - concludes Zaghetto - after following a MLS ® training course directly in ASAlaser last October, has used the therapy on many different occasions and just at the meeting, has said to be enthusiastic about results obtained with the apparatus>>.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.